Allouche Cyril

Track

Insider profile

Allouche Cyril's trades of Revance Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-03-19 2019-03-18
PlS Planned sale
91,721 +7.7%
148.66
US$1,463,411 		91,721 +7.7% 148.66 US$1,463,411
2019-01-23 2019-01-22
PlS Planned sale
72,286 +35.6%
258.47
US$336,286 		72,286 +35.6% 258.47 US$336,286
2019-01-04 2019-01-03
PlS Planned sale
92,537 +3.7%
97.92
US$4,895,622 		92,537 +3.7% 97.92 US$4,895,622